OMASS TECHNOLOGIES
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
OMASS TECHNOLOGIES
Industry:
Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.omass.com
Total Employee:
11+
Status:
Active
Contact:
01865 548350
Email Addresses:
[email protected]
Total Funding:
118 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Maps API Google Cloud OpenResty
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Sentinel Oncology
Sentinel Oncology is a drug discovery company specialising in the delivery of candidate drugs to treat diseases.
XRnanotech
XRnanotech is a deep tech company that offers innovative nanostructured X-ray optics for high-tech applications.
Current Advisors List
Current Employees Featured
Founder
Investors List
GV
GV investment in Series B - OMass Technologies
Northpond Ventures
Northpond Ventures investment in Series B - OMass Technologies
Syncona Partners LLP
Syncona Partners LLP investment in Series B - OMass Technologies
Oxford Science Enterprises
Oxford Science Enterprises investment in Series B - OMass Technologies
Sanofi Ventures
Sanofi Ventures investment in Series B - OMass Technologies
Syncona Partners LLP
Syncona Partners LLP investment in Series A - OMass Technologies
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - OMass Technologies
Syncona Partners LLP
Syncona Partners LLP investment in Series A - OMass Technologies
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - OMass Technologies
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - OMass Technologies
Key Employee Changes
Date | New article |
---|---|
2022-07-15 | OMass Therapeutics Appoints Dr Jon Roffey as Vice President, Head of Medicinal Chemistry |
Official Site Inspections
http://www.omass.com Semrush global rank: 3.88 M Semrush visits lastest month: 3.31 K
- Host name: 300480.cloudwaysapps.com
- IP address: 178.62.119.83
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1